Literature DB >> 28775398

CURRENT CONCEPTS IN NEUROCYSTICERCOSIS.

P C Sanchetee1.   

Abstract

Keywords:  Cysticercosis; Magnetic resonance imaging; Taenia solium

Year:  2017        PMID: 28775398      PMCID: PMC5531151          DOI: 10.1016/S0377-1237(17)30393-3

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


× No keyword cloud information.
  6 in total

1.  MR observations on the effects of praziquantel in neurocysticercosis.

Authors:  A Jena; P C Sanchetee; R Tripathi; R K Jain; A K Gupta; M L Sapra
Journal:  Magn Reson Imaging       Date:  1992       Impact factor: 2.546

2.  Immunization against porcine cysticercosis in an endemic area in Mexico: a field and laboratory study.

Authors:  J L Molinari; R Soto; P Tato; D Rodriguez; A Retana; J Sepulveda; A Palet
Journal:  Am J Trop Med Hyg       Date:  1993-10       Impact factor: 2.345

3.  Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluation.

Authors:  M Cruz; I Cruz; J Horton
Journal:  Trans R Soc Trop Med Hyg       Date:  1991 Mar-Apr       Impact factor: 2.184

4.  Cysticercosis of the brain shown by magnetic resonance imaging.

Authors:  A Jena; P C Sanchetee; R K Gupta; S Khushu; R Chandra; N Lakshmipathi
Journal:  Clin Radiol       Date:  1988-09       Impact factor: 2.350

Review 5.  The immunology of human and animal cysticercosis: a review.

Authors:  A Flisser; R Pérez-Montfort; C Larralde
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

6.  Albendazole therapy for neurocysticercosis.

Authors:  P C Sanchetee; S Venkataraman; R M Dhamija; A K Roy
Journal:  J Assoc Physicians India       Date:  1994-02
  6 in total
  1 in total

1.  Amplification of cestode DNA from the peri-anal region of naturally infected foxes by PCR and LAMP: proof of concept for a potential sampling strategy for diagnosing human taeniosis.

Authors:  Gillian Muchaamba; Cristian A Alvarez Rojas; Peter Deplazes
Journal:  Parasitol Res       Date:  2021-08-31       Impact factor: 2.383

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.